Daniel Salmon Keywords COVID-19 vaccine ADB John Hopkins SARS Clinical trial safety Health Read more about Daniel Salmon Dr. Salmon’s primary research and practice interest is optimizing the prevention of childhood infectious diseases through the use of vaccines. He is broadly trained in vaccinology, with an emphasis in epidemiology, behavioral epidemiology, and health policy. Dr.
SARS-CoV-2 and COVID-19 Clinical Trials and Vaccine Safety Read more about SARS-CoV-2 and COVID-19 Clinical Trials and Vaccine Safety Dr. Stephen Prior shared his insight on vaccination, vaccine safety, and efficacy. He also discussed the comparison of vaccine development processes and COVID-19 vaccine clinical trials.
Risk Communication: COVID-19 Vaccine Read more about Risk Communication: COVID-19 Vaccine Dr. Priscilla Rupali, in this presentation, shared insights on risk communications that emerged from the COVID-19 pandemic and how it has impacted the behaviors and willingness to follow public health and social measures.
Stephen Prior Keywords COVID-19 vaccine safety Health ADB Read more about Stephen Prior Dr. Stephen Prior is a Microbiologist and current President of Therax, Inc., USA
Lessons from COVID-19 in Asia and the Pacific, ADB’s response, and Asia Pacific Vaccine Access Facility (APVAX): A conversation with ADB experts Read more about Lessons from COVID-19 in Asia and the Pacific, ADB’s response, and Asia Pacific Vaccine Access Facility (APVAX): A conversation with ADB experts via Zoom Developing Asia and the Pacific has been hit hard by the COVID-19 pandemic, threatening hard-won gains in poverty reduction and the achievement of the Sustainable Development Goals – millions of people have been infected with COVID19 and regional economic output contracted for the first time since the 1960s.